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The promotion of health equity, the absence of avoidable and unfair differences in
health outcomes, is a global imperative. Systematic reviews are an important source of
evidence for health decision-makers, but have been found to lack assessments of the
intervention effects on health equity. The Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) is a 27-item checklist intended to improve the
transparency and reporting of systematic reviews. We developed an equity extension
for PRISMA (PRISMA-E 2012) to help systematic reviewers identify, extract, and
synthesise evidence on equity in systematic reviews. In this explanation and elabora-
tion paper we provide the rationale for each extension item. These items are additions
or modifications to the existing PRISMA Statement items, in order to incorporate a
focus on equity. An example of good reporting is provided for each item as well as the
original PRISMA item. This explanation and elaboration document is intended to
accompany the PRISMA-E 2012 Statement and the PRISMA Statement to improve
understanding of the reporting guideline for users. The PRISMA-E 2012 reporting
guideline is intended to improve the transparency and completeness of the reporting of
equity-focused systematic reviews. Improved reporting can lead to better judgement of
applicability by policymakers, which may result in more appropriate policies and
programmes and may contribute to reductions in health inequities. To encourage
wide dissemination of this article it is accessible on the International Journal for
Equity in Health, Journal of Clinical Epidemiology, and Journal of Development
Effectiveness websites.
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Introduction
Promoting health equity and reducing avoidable health inequalities is a global imperative,
endorsed by the Rio Summit in Brazil in 2011, the Pan American Health Organization,
and the World Health Organization (“Rio Political Declaration 2011”; PAHO 2009; WHO
2012). Health inequalities are differences in health outcomes across individuals in a
population or between different population groups, whereas health inequities are inequal-
ities that are avoidable and unfair (Whitehead 1992; Petticrew et al. 2004). Inequities are
not only due to poverty, but may also be due to unfair differences in health across other
characteristics such as sex/gender, geography, and ethnicity (O’Neill et al. 2014). The
concept of health equity also suggests that groups of people should not be prevented from
achieving health due to factors such as discrimination or inadequate access. In this
reporting guideline, we focus on unfair inequalities in health outcomes and therefore
use the term ‘equity’. See Box 1 for a description of the terminology related to dis-
advantaged populations that is used in this paper.
Systematic reviews are recognised as an important source of rigorously and transpar-
ently synthesised information by health decision-makers (PAHO 2009; Kelly et al. 2007;
Lavis 2009; PAHO 2007). Health decision-makers have described lack of evidence on
equity as a barrier to using systematic reviews and guidelines (Petticrew et al. 2004; Vogel
et al. 2013), and arguably, primary studies themselves. However, a 2010 systematic
review found that there is a lack of detail in the reporting of certain aspects important
to health equity including population characteristics, assessment of credibility of subgroup
analyses, and judgement about the applicability of the findings to other settings with fewer
than half of the included reviews reporting on socio-demographic characteristics (such as
age, sex, place of residence, ethnicity) of the study populations (Welch et al. 2010b).
These are important factors to consider for health equity and the lack of reporting of these
elements demonstrates the need to improve reporting of equity in systematic reviews, and
to increase the overall investment in systematic reviews that can provide a clear emphasis
on considerations of equity.
Reporting guidelines have been shown to improve the reporting of different study
designs (Turner et al. 2012; Panic et al. 2013). The Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) is a 27-item checklist to ensure
complete and transparent reporting of the methods used in systematic reviews
(Moher et al. 2009). However, the original PRISMA Statement did not include
items specific for reporting on considerations of equity. Equity considerations
include the definition of disadvantaged populations, methods to include equity
considerations in analyses, and applicability of the evidence to other settings or
populations. We developed an equity extension of the PRISMA Statement, called
PRISMA-E 2012, to respond to these needs (Welch et al. 2012b). As of 8 July 2015,
the PRISMA-E 2012 reporting guideline has been viewed almost 16,000 times,
downloaded 2661 times, cited 50 times (Scopus), and shared 109 times using
Twitter (99 tweets by 70 users according to Altmetrics). It is also cited as a reference
for the World Health Organization Handbook on Guideline Development, the Oxford
Textbook of Public Health, the Public Health Agency of Canada guidance,
the Canadian Institutes of Health Research instructions for applicants, and the
Journal of the Society for Social Work and Research. The Spanish version of
PRISMA-E 2012, published in July 2013, has been downloaded 477 times as of
17 November 2014 (Scielo) and has received 1474 visits on the journal’s website
(Welch et al. 2013).
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To further facilitate and promote the use of the guideline of equity issues in systematic
review (PRISMA-E 2012), we developed this explanation and elaboration to describe
each of the items and provide examples from existing reviews to demonstrate good
reporting.
Scope of PRISMA-E 2012
The PRISMA-E 2012 checklist was developed to improve the transparency and comple-
teness of the reporting of systematic reviews of intervention studies with a focus on health
equity. We define systematic reviews of intervention studies with a major focus on health
equity as those designed to:
(1) Assess the effects of interventions targeted at disadvantaged or at-risk populations
(e.g. school feeding for disadvantaged children (Miller, Maguire, and Macdonald
2011)). These may not include equity outcomes, but by targeting disadvantaged
populations they will reduce inequities.
(2) Assess the effects of interventions aimed at reducing social gradients across
populations or among subgroups of the population (e.g. interventions to reduce
the social gradient in smoking, obesity prevention in children, interventions
delivered by lay health workers (Welch et al. 2012b; Thomas et al. 2008;
Thomson et al. 2010; Waters et al. 2011)).
In the PRISMA-E 2012 Statement we had a third type of systematic review focused on
health equity, those that are not aimed at reducing inequities but where it may be
important to understand the equity effects. For example, we had previously categorised
the review examining lay health workers in this category. We have now grouped this
review into the second type of review described above.
In 2010, approximately 20 per cent of systematic reviews indexed in Medline met at
least one of the above criteria (Tsikata et al. 2003; Welch et al. 2010a). These reviews may
Box 1: Terminology related to disadvantaged populations
To describe the populations who are experiencing inequitable differences, we use the
term ‘disadvantaged’ although we recognise that this term may not be acceptable to
all. In a methodology review of equity assessment, disadvantage was defined in terms
of the avoidability or preventability of health inequalities (12 of 34 studies) (Welch
et al. 2010b) by focusing on populations that have experienced health inequities (e.g.
Aboriginal populations).
We have chosen to use the term ‘disadvantaged’ for PRISMA-E 2012 because we felt
that despite its limitations (e.g. that it may be considered a condescending or
paternalistic term), the term ‘disadvantaged’ more clearly defines a population that
is experiencing or has experienced health inequities. Vulnerability encompasses a
combination of risk, exposure, and resilience that do not always lead to health
inequities, and other terms such as ‘marginalised’ are too narrowly focused and do
not encompass the breadth of settings, contexts, and health inequities of interest.
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not include equity as an outcome, but may target disadvantaged populations, or assess
differences of the effect of the intervention among disadvantaged populations.
The PRISMA-E 2012 items are focused on health equity, but may also apply to
systematic reviews in non-health areas that address questions about inequity such as
education, transport, justice, or social welfare. Additionally, some items in the checklist
may be relevant to all systematic reviews, but have been included in this extension
because of their specific importance to health equity. These items are additions or
modifications to the existing PRISMA Statement items, in order to incorporate a focus
on equity. For each item, the original PRISMA item is listed and the PRISMA-E 2012
extension item is noted below.
Methods of PRISMA-E 2012 reporting guideline
To develop the PRISMA-E 2012 reporting guideline, we followed the series of steps
recommended by Moher and colleagues (2010), as reported in the previously published
paper (Moher et al. 2010). The first step was to identify need and review the literature. We
conducted a systematic review and a methodological study (Welch et al. 2010a, 2012c).
Next, we conducted an online survey whose respondents included systematic review
authors, policymakers, and systematic review funders (Welch et al. 2012b). Finally, we
held a consensus meeting of international experts from 9 to 10 February 2012 at the
Rockefeller Foundation’s Bellagio Conference Centre in Bellagio, Italy. We took detailed
minutes at the meeting and used these minutes to revise the PRISMA-E statement and
develop this explanation and elaboration document. The complete PRISMA-E 2012
checklist is provided in Table 1.
Table 1. Checklist of items for reporting equity-focused systematic reviews.
Section Item Standard PRISMA Item
Extension for Equity-Focused
Reviews
Title
Title 1 Identify the report as a systematic
review, meta-analysis, or both.
Identify equity as a focus of the
review, if relevant, using the term
equity.
Abstract
Structured
summary
2 2. Provide a structured summary
including, as applicable:
background; objectives; data
sources; study eligibility criteria,
participants, and interventions;
study appraisal and synthesis
methods; results; limitations;
conclusions and implications of
key findings; systematic review
registration number.
State research question(s) related to
health equity.
2A Present results of health equity
analyses (e.g. subgroup analyses
or meta-regression).
2B Describe extent and limits of
applicability to disadvantaged
populations of interest.
(Continued )
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Table 1. (Continued ).
Section Item Standard PRISMA Item
Extension for Equity-Focused
Reviews
Introduction
Rationale 3 Describe the rationale for the
review in the context of what is
already known.
Describe assumptions about
mechanism(s) by which the
intervention is assumed to have
an impact on health equity.
3A Provide the logic model/analytical
framework, if done, to show the
pathways through which the
intervention is assumed to affect
health equity and how it was
developed.
Objectives 4 Provide an explicit statement of
questions being addressed with
reference to PICOS.
Describe how disadvantage was
defined if used as criterion in the
review (e.g. for selecting studies,
conducting analyses, or judging
applicability).
4A State the research questions being
addressed with reference to
health equity
Methods
Protocol and
registration
5 Indicate if a review protocol exists,
if and where it can be accessed
(e.g. web address), and, if
available, provide registration
information including registration
number.
Eligibility criteria 6 6. Specify study characteristics (e.g.
PICOS, length of follow-up) and
report characteristics (e.g. years
considered, language, publication
status) used as criteria for
eligibility, giving rationale.
Describe the rationale for including
particular study designs related to
equity research questions.
6A Describe the rationale for including
the outcomes (e.g. how these are
relevant to reducing inequity).
Information
sources
7 Describe all information sources
(e.g. databases with dates of
coverage, contact with study
authors to identify additional
studies) in the search and date
last searched.
Describe information sources (e.g.
health, non-health, and grey
literature sources) that were
searched that are of specific
relevance to address the equity
questions of the review.
Search 8 Present full electronic search
strategy for at least one database,
including any limits used, such
that it could be repeated.
Describe the broad search strategy
and terms used to address equity
questions of the review.
Study selection 9 State the process for selecting
studies (i.e. screening, eligibility,
included in systematic review,
and, if applicable, included in the
meta-analysis).
(Continued )
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Table 1. (Continued ).
Section Item Standard PRISMA Item
Extension for Equity-Focused
Reviews
Data collection
process
10 Describe the method of data
extraction from reports (e.g.
piloted forms, independently, in
duplicate) and any processes for
obtaining and confirming data
from investigators.
Data items 11 List and define all variables for
which data were sought (e.g.
PICOS, funding sources) and any
assumptions and simplifications
made.
List and define data items related to
equity, where such data were
sought (e.g. using PROGRESS-
Plus or other criteria, context).
Risk of bias in
individual
studies
12 Describe methods used for
assessing risk of bias of
individual studies (including
specification of whether this was
done at the study or outcome
level), and how this information
is to be used in any data
synthesis.
Summary
measures
13 State the principal summary
measures (e.g. risk ratio,
difference in means).
Synthesis of
results
14 Describe the methods of handling
data and combining results of
studies, if done, including
measures of consistency (e.g. I2)
for each meta-analysis.
Describe the methods of
synthesising findings on health
inequities (e.g. presenting both
relative and absolute differences
between groups).
Risk of bias
across studies
15 15. Specify any assessment of risk
of bias that may affect the
cumulative evidence (e.g.
publication bias, selective
reporting within studies).
Additional
analyses
16 Describe methods of additional
analyses (e.g. sensitivity or
subgroup analyses, meta-
regression), if done, indicating
which were pre-specified.
Describe methods of additional
synthesis approaches related to
equity questions, if done,
indicating which were pre-
specified
Results
Study selection 17 Give numbers of studies screened,
assessed for eligibility, and
included in the review, with
reasons for exclusions at each
stage, ideally with a flow
diagram.
Study
characteristics
18 For each study, present
characteristics for which data
were extracted (e.g. study size,
PICOS, follow-up period) and
provide the citations.
Present the population
characteristics that relate to the
equity questions across the
relevant PROGRESS-Plus or
other factors of interest.
Risk of bias
within studies
19 Present data on risk of bias of each
study and, if available, any
outcome-level assessment (see
item 12).
(Continued )
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Table 1. (Continued ).
Section Item Standard PRISMA Item
Extension for Equity-Focused
Reviews
Results of
individual
studies
20 For all outcomes considered
(benefits or harms), present, for
each study: (a) simple summary
data for each intervention group;
(b) effect estimates and
confidence intervals, ideally with
a forest plot.
Synthesis of
results
21 Present results of each meta-
analysis done, including
confidence intervals and
measures of consistency.
Present the results of synthesising
findings on inequities (see 14).
Risk of bias
across studies
22 Present results of any assessment of
risk of bias across studies (see
item 15).
Additional
analysis
23 Give results of additional analyses,
if done (e.g. sensitivity or
subgroup analyses, meta-
regression [see item 16]).
Give the results of additional synthesis
approaches related to equity
objectives, if done, (see 16).
Discussion
Summary of
evidence
24 Summarise the main findings
including the strength of
evidence for each main outcome;
consider their relevance to key
groups (e.g. health-care
providers, users, and
policymakers).
Limitations 25 Discuss limitations at study and
outcome level (e.g. risk of bias),
and at review-level (e.g.
incomplete retrieval of identified
research, reporting bias).
Conclusions 26 Provide a general interpretation of
the results in the context of other
evidence, and implications for
future research.
Present the extent and limits of
applicability to disadvantaged
populations of interest and
describe the evidence and logic
underlying those judgments.
26A Provide implications for research,
practice, or policy related to
equity where relevant (e.g. types
of research needed to address
unanswered questions).
Funding
Funding 27 Describe sources of funding for the
systematic review and other
support (e.g. supply of data); role
of funders for the systematic
review.
Note: This checklist should be read in conjunction with the Statement and Explanation and Elaboration
document.
PICOS, participants, interventions, comparisons, outcomes, and study design.
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How to use this paper
The format of this document is similar to the format used in other explanation and
elaboration documents (Altman et al. 2001; Bossuyt et al. 2003; Vandenbroucke et al.
2007; Liberati et al. 2009; Boutron et al. 2008). We feel this explanation and elaboration
paper is an important contribution to the literature because it provides the detailed
rationale, evidence, whenever available, and an exemplar, for recommending each item
as well as examples of good practice. We recommend authors use this document in
conjunction with the PRISMA-E 2012 statement and with the original PRISMA statement
and explanation and elaboration papers. We use the term ‘we’ to refer to the consensus
panel that met to finalise the PRISMA-Equity 2012 reporting guidelines in February 2012,
as well as those who were unable to attend but contributed to the final reporting
guidelines.
Item 1: title
Standard PRISMA item. Identify the report as a systematic review, meta-analysis or both.
In addition, for equity-focused systematic reviews: Identify equity as a focus of the
review, if relevant, using the term equity.
Examples
● ‘Inequity in childhood immunization in India: a systematic review’ (Mathew 2012)
● ‘Can cost-effectiveness analysis integrate concerns for equity? Systematic review’
(Johri and Norheim 2012)
Explanation – Equity-focused systematic reviews need a concise title that includes the
term ‘equity’ or ‘inequity’. At the consensus meeting, the panel felt strongly that a
consistent term was needed in the title to help identify equity-focused reviews and we
chose the term ‘equity’ because of our focus on unfair inequalities in health. Indexing of
electronic databases is poor for terms relating to health equity or disadvantaged or
vulnerable populations; therefore we suggest including ‘equity’ in the title will facilitate
searching for equity-focused reviews. Not all systematic reviews will include equity in the
title; thus, to improve searchability, ‘equity’ should be included in the abstract and/or
keywords. This will also help policymakers find equity-focused systematic reviews. In a
search of systematic reviews published in the last year in MEDLINE, we only found 11
with ‘equity’ in the title and 73 with equity in the title and/or abstract (Table 2).
Table 2. Systematic reviews with equity in the title (28 November 2013 to 27 November 2014).
Query
Items
Found
(equit*[ti] OR inequit*[ti]) AND (MEDLINE[Title/Abstract] OR (systematic[Title/
Abstract] AND review[Title/Abstract]) OR meta-analysis[Publication Type])
11
(equit*[Title/Abstract] OR inequit*[Title/Abstract]) AND (MEDLINE[Title/
Abstract] OR (systematic[Title/Abstract] AND review[Title/Abstract]) OR
meta-analysis[Publication Type])
73
(MEDLINE[Title/Abstract] OR (systematic[Title/Abstract] AND review[Title/
Abstract]) OR meta-analysis[Publication Type])
19885
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Item 2: abstract
Standard PRISMA item. Provide a structured summary including, as applicable: back-
ground; objectives; data sources; study eligibility criteria, participants, and interventions;
study appraisal and synthesis methods; results; limitations; conclusions and implications
of key findings; systematic review registration number.
In addition, for equity-focused systematic reviews: State research question(s) related
to health equity.
Example
● ‘We aimed to systematically assess current evidence for the association between
socioeconomic position (SEP) and caries. We included studies investigating the
association between social position (determined by own or parental educational or
occupational background, or income) and caries prevalence, experience, or inci-
dence.’ (Schwendicke et al. 2014)
● ‘Our primary outcome is the utilization of [post-natal care] PNC services, and
determinants of concern are: 1) socioeconomic status (for example, income, educa-
tion); 2) geographic determinants (for example, distance to a health center, rural
versus urban residence); and 3) demographic determinants (for example, ethnicity,
immigration status)’ (Langlois et al. 2013)
Explanation – The abstract of the review needs to indicate whether the research questions
and objectives are of relevance to equity or specific populations since some readers,
including those making decisions about health programmes and policies, may only have
access to the abstract (or only read the abstract). Thus, we recommend research questions
related to health equity should be reported in the abstract to facilitate their retrieval for
decision-making. We also recommend describing the type of inequities addressed by the
review (e.g. health outcomes, health service coverage or access, financial risk).
Item 2A: in addition, for equity-focused systematic reviews: Present results of health
equity analyses (e.g. subgroup analyses or meta-regression).
Example
● ‘No strong evidence of differential effects was found for smoking restrictions in
workplaces and public places, although those in higher occupational groups may
be more likely to change their attitudes or behaviour. Smoking restrictions in
schools may be more effective in girls. Restrictions on sales to minors may be
more effective in girls and younger children. Increasing the price of tobacco
products may be more effective in reducing smoking among lower income adults
and those in manual occupations, although there was also some evidence to
suggest that adults with higher levels of education maybe more price sensitive.
Young people aged under 25 are also affected by price increases, with some
evidence that boys and non-white young people may be more sensitive to price.’
(Thomas et al. 2008)
Explanation – Findings related to equity questions should be presented in the abstract
along with the main results. In addition, the abstract needs to differentiate between the
main analyses and other analyses as well as any null findings. Of the 182 abstracts, 42
per cent do not describe the direction of the main effect in words, and 25 per cent do
not provide numerical results (Beller et al. 2011). For equity-focused reviews, we have
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found that equity findings (e.g. subgroup analyses by socioeconomic status or other
indicators) are not well reported in the abstract. Including the equity findings in the
abstract may facilitate finding equity-focused reviews. As mentioned above, some
readers only read or have access to the abstract. We felt that including equity findings
in the abstract will be helpful for users to determine whether the review is of interest.
Therefore, the abstract should describe all relevant effects on health equity, both
beneficial and harmful, as well as the methods used to assess health equity (White,
Adams, and Heywood 2009).
As recommended by PRISMA for abstracts (Beller et al. 2013), the authors should
report the main results in both numbers and words to meet the needs of different users.
Item 2B: in addition, for equity-focused systematic reviews: Describe extent and limits
of applicability to disadvantaged populations of interest.
Example
● ‘Conditional cash transfer programmes have been the subject of some well-designed
evaluations, which strongly suggest that they could be an effective approach to
improving access to preventive services. Their replicability under different condi-
tions – particularly in more deprived settings – is still unclear because they depend
on effective primary health care, and mechanisms to disburse payments. Further
rigorous evaluative research is needed, particularly where [conditional cash trans-
fers] CCTs are being introduced in low income countries, for example in Sub-
Saharan Africa or South Asia.’ (Lagarde, Haines, and Palmer 2009)
Explanation – Since the abstract may be all that a reader accesses, it is important that the
abstract reports the extent and limits of applicability of the findings of the review in
relation to equity concepts. We felt this information is important to all consumers and
users of the review, including patients, practitioners, policymakers, press, and the public.
The reporting of applicability is not intended to be a recommendation for practice or
policy. It is instead intended to provide the reader with information regarding the primary
studies and the results of the review and how the results of equity considerations apply.
While there is insufficient space to report applicability considerations for all populations,
we felt that applicability to the target population of the review should be reported.
Introduction section
Item 3: rationale
Standard PRISMA item. Describe the rationale for the review in the context of what is
already known.
In addition, for equity-focused systematic reviews: Describe assumptions about
mechanism(s) by which the intervention is assumed to have an impact on health equity.
Examples
● ‘CCT programs are justified on the grounds that demand-side subsidies are needed
to address constraints and bottlenecks of service delivery. CCT programs usually
aim to increase demand for preventive health services and education because these
services have positive spillover effects that justify the expense. CCT help overcome
barriers to access of services. These programs address social equity concerns
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because CCT can help to “level the playing field” thus creating equal opportunities.’
(Lagarde, Haines, and Palmer 2009)
● ‘Many lay health worker programs aim to address inequity by providing services to
underserved communities.’ (Lewin et al. 2010)
Explanation – If available, systematic reviews with a focus on health equity should
explicitly describe the assumptions about the effects of the intervention on health equity,
or drivers of health inequity. Assumptions about outcomes along the causal chain and
these hypotheses about health equity may be articulated using different methods such as a
programme theory and can then be tested empirically with pre-planned analyses in the
review (Waddington et al. 2012; Snilstveit 2012). The review should describe a priori how
and why interventions are expected to work and the influence of factors such as setting
and participant and programme characteristics. This explicit reporting of assumptions and
underlying hypotheses will help the reader understand the choice of methods to assess the
effects on health equity and the interpretation of results within the framework of these
hypotheses.
Item 3A: in addition, for equity-focused systematic reviews: Provide the logic model/
analytical framework, if done, to show the pathways through which the intervention is
assumed to affect health equity and how it was developed.
Examples
Figure 1 (Waddington and White 2014; White 2014)
Figure 2 (Niederdeppe et al. 2008)
Explanation – Health equity is influenced by multiple interacting factors such as context,
setting, population characteristics, environment, public policy setting, health facility
factors, and health provider factors (Whitehead 1992; Braveman and Gruskin 2003;
Tugwell et al. 2006). A visual framework, or logic model, can show the links between
these factors, the programme or intervention of interest, and the hypothesised effects on
health equity. It can be used to show hypothesised pathways of influence on health equity,
to focus the review, define the inclusion criteria, identify intermediate outcomes and
harms, define the search strategy, and plan subgroup and effect modifier analyses
(Anderson et al. 2011). For example, the logic model for a systematic review of preschool
Figure 1. Item 3A, example 1 – Analytic framework.
Source: This is an example of a ‘funnel of attrition’. (Waddington and White 2014; White 2014).
Journal of Development Effectiveness 297
feeding shows that low socioeconomic status and household size may increase the risk of
substitution (less food at home), thus decreasing the observed effects of preschool feeding
(Kristjansson et al. 2012). A visual framework can be useful for policymakers and
decision-makers who seek to answer questions about the effects of both targeted and
universal interventions and how these programmes will work in their policy/decision-
making settings and system. For complex interventions, a visual framework can help the
reader unpack the ‘black box’, thus showing how the intervention might affect different
subgroups of the population and can be used as a tool for articulating subgroup analyses a
priori.
Many different methods exist for developing a logic model, and different logic
models have been developed for the same question. Guidance for how to construct a
logic model is available from the Cochrane Public Health Group and the Kellogg
Foundation (Armstrong, Waters, and Doyle 2011; “Logic Model 2004”; Rogers 2014;
Vogel 2012).
Item 4: objectives
Standard PRISMA item. Provide an explicit statement of questions being addressed with
reference to participants, interventions, comparisons, outcomes, and study design
(PICOS).
Figure 2. Item 3A, example 2 – analytic framework.
Source: This is an example of a logic model (Niederdeppe et al. 2008).
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In addition, for equity-focused systematic reviews: Describe how disadvantage was
defined if used as criterion in the review (e.g. for selecting studies, conducting analyses,
or judging applicability).
Example
● ‘For the purposes of this review, the term ‘disadvantaged’ is taken to denote women
whom the primary investigators considered to be of low socio-economic status or
educationally disadvantaged, or who are under the age of 20[children born to
teenage mothers in the UK have been estimated to have a 63% increased likelihood
of being born into poverty], or who are caring for children in single-parent house-
holds.’ (Macdonald et al. 2010)
● ‘Parents with children up to the age of school entry and who were socially
disadvantaged in respect of poverty, lone parenthood or ethnic minority status.’
(Miller, Maguire, and Macdonald 2011)
● ‘We will retrieve studies implemented in low- and middle-income countries
[LMICs], as defined by The World Bank Group’s classification. . . which study
access to or utilization of PNC services by birthing women living in resource
strained settings.’ (Langlois et al. 2013)
Explanation – Description of the specific population in the PICOS (Population,
Intervention, Comparator, Outcome, Study Design) framework does not encompass expli-
cit definition of how disadvantage or risk of inequity will be assessed, for example in
reference to which group, disadvantaged by what mechanisms, and for which outcomes.
Populations are at risk of health disadvantage for many different reasons that may interact
with each other. There are many examples of factors that may contribute to disadvantage
and these may interact with each other, such as geographical isolation, lack of access to
health facilities, biologic vulnerability, historical oppression, social exclusion, health or
language literacy, low resource settings, inadequate health systems, inadequate health
insurance, health provider attitudes, stigmatisation, and discrimination (O’Neill et al.
2014). Systematic review authors can group such factors using the PROGRESS-Plus
acronym: Place of residence, Race/ethnicity/culture/religion, Occupation, Gender/sex,
Religion, Social Capital, Socioeconomic status (O’Neill et al. 2014; Evans and Brown
2003). However, grouping populations that share one characteristic across PROGRESS-
Plus may lead to overgeneralisation since people within one category are heterogeneous
(e.g. women range from poor to wealthy, with very different personal histories and
exposures to health risks).
An explicit definition of how disadvantage will be assessed in the systematic review,
either for targeted interventions or for subgroup analyses of universal interventions, is
necessary to increase the likelihood that similar groups of people are compared, to make
explicit the proposed reasons those people are considered disadvantaged, to explain why
and how the programme is expected to work for people at different risk of health
disadvantage, and to facilitate judgments about applicability in different settings and
populations. If disadvantage is used as a criterion, it needs to be defined, as well as the
proposed reasons for disadvantage (e.g. biologic, societal), and the comparator or refer-
ence group against which disadvantage is assessed. Disadvantage and vulnerability may
be poorly reported in primary studies. However, systematic review authors should
describe how they have operationalised their definition of disadvantage or inequity in
their inclusion criteria, analyses, and judgements of applicability. For example, if
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economically disadvantaged populations are the focus of the review, then a description of
this population should be provided.
Item 4A: in addition, for equity-focused systematic reviews: State the research ques-
tions being addressed with reference to health equity.
Examples
● Two objectives ‘To determine the effectiveness of school feeding programs in
improving physical and psychosocial health outcomes for low income school
children.’ And ‘To compare the effectiveness of school feeding programmes for
socio-economically disadvantaged children and advantaged children.’ (Kristjansson
et al. 2007)
● ‘To assess the impact on maternal and infant health and on infant development of
programmes offering home support in addition to the standard service for teenaged
mothers (ages less than 20 years) who had recently given birth and who were
socially or economically disadvantaged, for example because they were poor,
lived inner city or were single parents.’ (Macdonald et al. 2010)
Explanation – If assessing the impact on inequities is an objective of the review, the
research questions related to this objective should be stated. Potentially important sub-
group effects are differences in the relative effect that are large enough that users might
make different decisions based on the subgroup effect than they would be based on the
overall effect. Review authors should give consideration to all potentially disadvantaged
groups for which the intervention might have a different effect based on the intervention’s
mechanism of action, including economic status, employment or occupation, education,
place of residence, gender, and ethnicity.
Consideration of differences in relative effects for disadvantaged populations should
be addressed similarly to any other subgroup analysis. As such, authors should distinguish
between protocol and review items. The protocol should indicate plans for any subgroup
analyses, including specifying which subgroups will be investigated, the predicted direc-
tion of the subgroup effect, and the indirect evidence supporting the prediction (e.g.
biological or sociological rationale; studies of other relevant populations, interventions,
or outcomes) (Sun et al. 2010, 2012). Only a small number of subgroups (i.e. only those
for which there is a plausible reason such as indirect evidence for anticipating a subgroup
effect) should be investigated.
Methods section
Item 6: eligibility criteria
Standard PRISMA item. Specify study characteristics (e.g. PICOS, length of follow-up)
and report characteristics (e.g. years considered, language, publication, status) used as
criteria for eligibility, giving rationale.
In addition, for equity-focused systematic reviews: Describe the rationale for includ-
ing particular study designs related to equity research questions.
Examples
● ‘Cross-sectional quantitative study designs, qualitative study designs, or a com-
bination of the two (mixed-methods studies). Specifically, we included, first, any
type of cross-sectional study design reporting quantitative data. Second,
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qualitatively-based studies had to have used either individual interviews or focus
group interviews to collect data about [female genital mutilation/cutting] FGM/C
and used qualitative data analysis methods, such as thematic analysis, to be
eligible for inclusion. Third, mixed-methods studies that incorporated both quan-
titative and qualitative components where the research design matched the nomi-
nated study designs were included. Both the quantitative and the qualitative
components of the study were subjected to the same inclusion criteria as the
mono-methods studies and the study was only included when the inclusion
criteria were met.’ (Berg and Denison 2012)
● ‘We included qualitative studies and studies using descriptive statistics which met
the following criteria:
(1) reported on interventions as identified as “farmer field schools”, although not
necessarily the same interventions as those included in the review of effects
(review question 1);
(2) assessed determinants of service delivery quality, knowledge acquisition, adop-
tion of technological improvements, diffusion, or sustainability (either directly
or indirectly – for example, studies that were relevant to addressing barriers to
and enablers of [farmer field schools] FFS effectiveness). . .’ (Waddington et al.
2014)
Explanation – Evidence on equity impacts may come from a range of study designs,
depending on the question, and the study designs included in a systematic review should
be chosen based on the question according to their ‘fitness for purpose’ (Petticrew and
Roberts 2003). The evidence of effects might have been assessed using randomised
controlled trials (RCTs) or other intervention study designs such as interrupted time series
or controlled before–after study. However, for many equity-focused reviews examining
social or public health interventions, the context in which the intervention operates is
important and may be reported in qualitative studies (Petticrew and Roberts 2003).
Evaluations of policy-level and other interventions that have implications for reducing
inequity and may provide important insight into the effects on equity may have been
evaluated using non-randomised designs (e.g. natural experiments).
Authors should be able to capture different types of evidence through the inclusion of
different study designs, but should justify the inclusion of these designs and provide the
rationale. For example, barrier and facilitator data collection and analysis often require
quantitative and qualitative data. New authors may not be aware of the rationale for
preferred study designs. While most systematic reviews just list study design without
rationale, the need to explain the rationale is not just an issue for equity, it should always
be reported.
Item 6A: in addition, for equity-focused systematic reviews: Describe the rationale for
including the outcomes (e.g. how these are relevant to reducing inequity).
Examples
● ‘Other smoking-related outcomes included compliance with age-of-sale legislation,
density of advertising and vending machines, brand appeal, and awareness and
receptivity to antismoking campaigns. This broad range of smoking-related out-
comes was included in order to encompass the diverse ways in which tobacco
control policies can influence youth smoking-related outcomes.’ (Brown, Platt,
and Amos 2014a)
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● ‘Changes in equity of access – increased access for disadvantaged groups or a
reduction in gaps in coverage – could also be an important outcome measure.
This required a preliminary analysis and categorisation of the population of interest
along a socio-economic scale. We accepted any relevant methodology (e.g. wealth/
asset index) provided it was rigorous and described in detail.’ (Lagarde, Haines, and
Palmer 2009)
Explanation – As with all systematic reviews, outcomes need to be selected based on
their relevance to the relevant stakeholder and/or user group (e.g. subjects/patients,
practitioner (and the patient–practitioner dyad), the public, policymakers, and politi-
cians). Equity-focused systematic reviews must, in addition, consider the relevance
and importance of outcomes across categories of disadvantage that are deemed rele-
vant for the review, including both health and non-health outcomes. Non-health-related
outcomes can have direct impacts on health and equity. For example, the Whitehall
study found that employment grade levels are related to health differences in which
people with lower-grade jobs have higher rates of mortality and diseases, such as
ischaemic heart disease, and lower self-perceived health status (Marmot et al. 1991).
In addition, measures may need to be developed and/or adapted to ensure that the
methodology does not disadvantage participation of bias results across populations.
Other situations are often found when a measure may be used across a population,
and where the intervention effectiveness is analysed according to cultural diversity
within the population. For example, a systematic review of culturally appropriate
health education assessed the influence of culturally adapted measurement tools on
knowledge outcomes using sensitivity analysis. (Attridge et al. 2014). The impor-
tance of outcomes for different settings and populations needs to be rated when
selecting major outcomes, for example, in Summary of Findings (SOF) Tables for
Cochrane reviews. An SOF table presents the main findings of the review for up to
seven patient-important outcomes and rates the quality of the evidence (Higgins and
Green 2011). SOFs are intended for those using the review, such as decision-makers
(Guyatt et al. 2011).
Context, inconvenience, and burden (e.g. financial burden) for populations need to be
considered as potentially important outcomes in equity-focused reviews even if they are
not commonly reported in primary studies. Financial burden may be relatively greater for
those who are poor and other burdens, such as stigma or travel time, may be different for
different populations.
Equity of access to care and coverage of health services are important outcomes for
some interventions that seek to improve access. Horizontal equity implies equal health
care for equal need, whereas vertical equity implies greater health care for greater need.
Authors should take a pragmatic approach to assessing the equity of access.
Item 7: information sources
Standard PRISMA item. Describe all information sources (e.g. databases with dates of
coverage, contact with study authors to identify additional studies) in the search and date
last searched.
In addition, for equity-focused systematic reviews: Describe information sources (e.g.
health, non-health, and grey literature sources) that were searched that are of specific
relevance to address the equity questions of the review.
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Examples
● ‘We chose to restrict our search of electronic databases to the 20 databases that had
produced the highest yield in the search for a previous systematic review on a
related topic, the health effects of new roads.
● We developed our search syntax iteratively. We first conducted a scoping search
with a provisional set of terms, retrieved the 100 most relevant abstracts, and then
added additional indexing or text word terms used in those references to our search
strategy. We then adapted the search syntax for each database or interface used. We
did not limit the search using terms for study design.
● We decided not to attempt a ‘‘systematic’’ internet search. Instead, we used three
quality assured gateway sites (http:// www.omni.ac.uk, http://www.sosig.ac.uk, and
http://www. eevl.ac.uk) and our own knowledge to generate lists of potentially
relevant websites, from which we selected a purposive sample of 16 sites that
contained bibliographies or searchable databases of documents. These represented
a range of types of organisation (academic, government, and voluntary), countries of
origin (Canada, all the countries of the European Union, Norway, and the United
States of America), and language of publication (Danish, English, French,
Norwegian, and Swedish).’ (Ogilvie et al. 2005)
● ‘We searched the following electronic databases for primary studies:
The Cochrane Central Register of Controlled Trials (CENTRAL) 2009, Issue 1, part of the The
Cochrane Library (www.thecochranelibrary.com) including the Cochrane Effective Practice and
Organisation of Care (EPOC) Group Specialised Register (searched 3 March 2009)
MEDLINE, Ovid In-Process & Other Non-Indexed Citations and MEDLINE, Ovid (1948 to
present) (searched 24 June 2011)
EMBASE, Ovid (1980 to 2009 Week 09) (searched 2 March 2009)
PsycINFO, Ovid (1806 to February Week 4 2009) (searched 4 March 2009)
EconLit, Ovid (1969 to February 2009) (searched 5 March 2009)
Sociological Abstracts, CSA (1952 to current) (searched 8 March 2009)
Social Services Abstracts, CSA (1979 to current) (searched 8 March 2009)
LILACS (searched 6 May 2009)
WHOLIS (searched 7 May 2009)
World Bank
Science Citation Index Expanded (SCI-EXPANDED) (1975 to present) (searched 8
September 2010)
Social Sciences Citation Index (SSCI) (1975 to present) (searched 8 September 2010).In
addition we selected relevant databases from the LMIC database list at: http://epocoslo.
cochrane.org. We did not search CINAHL or International Pharmaceutical Abstracts, so it is
possible that studies relating to nursing or pharmaceuticals were missed. However, the general
searches, including in websites focused on this topic, did not suggest that we had missed any
relevant studies. We will add these databases when the review is updated.’ (Witter et al. 2012)
Explanation – Equity-focused reviews often go beyond issues of health and bridge other
disciplines and thus information sources. For equity-focused systematic reviews, sources of
information beyond the well-known health databases may be required. The search strategy
may require inclusion of sources of information from different disciplines and different
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databases (e.g. sociological abstracts, IDEAhealth, non-health transportation or environ-
mental content databases, and discipline-specific grey literature). Authors should describe
all sources of information used for the search and provide a brief description of each, and
justify why these information sources were considered necessary and appropriate.
Some relevant information may be available only to members of a certain association
or working group. It would therefore be helpful for authors to report the accessibility of
the sources of information in addition to website links or other information that may help
the reader identify where the information has originated.
Item 8: search
Standard PRISMA item. . Present full electronic search strategy for at least one database,
including any limits used, such that it could be repeated.
In addition, for equity-focused systematic reviews: Describe the broad search strategy
and terms used to address equity questions of the review.
Example
See Table 3
Explanation – Authors of equity-focused systematic reviews should report the search
strategy and search terms used to identify the sources relevant to the equity questions.
Equity questions may require comprehensive textword searches to identify specific popula-
tions, multi-component interventions, or settings of interest that may require combinations of
text words. Additionally, equity-relevant reviewsmay relate to stigmatised populations, where
language has evolved in order to identify the communities in a non-stigmatised way. Any
search terms used should be clearly reported to ensure that the reader can duplicate the search.
We do not suggest limiting the search to equity-relevant terms unless these equity search
strategies have been validated. For example, the Cochrane Child Health filter has been
validated (Leclercq, Leeflang, and van-Dalen 2010). Other validated search filters are col-
lected in a repository by the InterTASC Information Specialists’ Sub-Group Search Filter
Resource. There is also ongoing work to validate a filter for identifying sex-specific analyses
(Moerman, Deurenberg, and Haafkens 2009). See Box 2 for more information on searching.
Item 11: data items
Standard PRISMA item. List and define all variables for which data were sought (e.g.
PICOS, funding sources) and any assumptions and simplifications made.
Box 2: A note about searching
Caution should be used when developing the search strategy. Limiting the search
using equity-related search terms is not recommended as many studies are not
indexed using equity-related terms and potentially relevant studies could be missed.
For equity-focused reviews, the search strategy may need to be broadened to reduce
the risk of missing potentially included studies. Review authors should plan more
time for screening.
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Table 3. Review of the research on the effectiveness of health service interventions to reduce
variations in health.
Medline [. . .]
Using CD Plus Ovid software, searching only from 1990 to December 1994 with no language
limitations and no publication type limitations.
Group 2: Describing possible strategies to reduce variation in health
011 consumer advocacy/
012 health promotion/
013 exp health planning/
014 insurance, health/
015 exp preventive health services/
016 exp health policy/
017 marketing of health services/
018 mass media/ 133
019 parenting/
020 primary health care/
021 exp public health/
022 exp self-help groups/
023 smoking cessation/
024 social support/
025 urban renewal/
026 exp public assistance/
027 health services accessibility/
028 delivery of health care/
029 environmental health/
030 exp patient acceptance of health care/
031 quality assurance, healthcare/
032 social change/
033 social justice/
034 public health/
035 accident prevention/
036 accidental falls/pc
037 accidents, home/pc
038 accidents, occupational/pc
039 accidents, traffic/pc
040 drowning/pc
041 consumer product safety/
042 disease outbreaks/pc
043 disease reservoirs/pc
044 disease transmission, patient-to-Professional/pc
045 disease transmission, Professional-to-patient/pc
046 environmental pollution/pc
047 health education/
048 hygiene/
049 sanitation/
050 insurance, medigap/
051 exp medicare/
052 medicare assignment/
053 medicaid/
054 ((free adj care) or ((nursery or preschool) adj education))).tw.
055 (after adj school adj care).tw.
056 (social adj support).tw.
Group 3: Describing possible associations of variations in health
057 housing/
058 public housing/
(Continued )
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In addition, for equity-focused systematic reviews: List and define data items related to
equity, where such data were sought (e.g. using PROGRESS-Plus or other criteria, context).
Example
● ‘…extracted data on study design, description of the intervention (including
process), details on participants (including age, sex, number in each group),
length of intervention, definition of poor/low income, other socio-demographic
variables, including place of residence, race/ethnicity, age, and nutritional status,
critical appraisal (see below), physical, cognitive, and behavioural outcomes. We
had planned to extract data on cost-effectiveness, but found none. Where
Table 3. (Continued ).
Medline [. . .]
059 nutritional status/
060 age factors/
061 uncompensated care/
062 socioeconomic factors/ 134
063 social class/
064 single parent/
065 exp ethnic groups/
066 poverty/
067 poverty areas/
068 unemployment/
069 rural health/
070 rural population/
071 urban health/
072 educational status/
073 urban population/
074 urbanization/
075 exp homeless persons/
076 medically uninsured/
077 medically underserved area/
078 (underinsured or uninsured or uncompensated or indigen$ or (ethnic adj difference#)).tw.
079 (unemployed or unemployment or (low adj income#) or blacks or deprived or
deprivation).tw.
080 (disadvantaged or endowed or unendowed or education$ or equity or equitable).tw.
081 (inequity or inequities or inequitable or unequal or homelessness or illiterate).tw.
082 (inequality or inequalities or variation# or poverty or underprivileged).tw.
083 (family adj income) or (inner adj cit$) or (minority adj group#) or (vulnerable adj
group#)).tw. nutritional status/ or nutrition.tw.
084 minority groups/
085 [(((low or lower or less or poor or poorer or level) adj2(socieconomic or
education$)).tw.]
086 (workplace or ((manual adj worker#) or occupation#) or (blue adj collar)).tw.
Group 4: Describing the characteristics potentially responsive to the intervention
087 exp health services/ec,og,st,sd,td,ut
088 exp vital statistics/
089 (health adj effects).tw.
090 health services accessibility/
091 ((campaign# or program# or intervention#) adj4 (access or accessibility or utili#ation
092 uptake or effect#).tw.
(Arblaster et al. 1996)
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possible, we recorded effects by socio-economic position.’ (Kristjansson et al.
2007)
Explanation – It is important for equity-focused systematic reviews to report all items for
which data were sought even if the information was not available from the primary studies.
Authors should explain the reasons for seeking data on these characteristics. If possible,
authors should consider making their data extraction forms available online (e.g. as web-only
appendices) or by request so that others may use or amend the forms in their own reviews.
Other data items that relate to the context of the population or intervention should also
be reported as well as any interactions between context and PROGRESS-Plus factors.
Each characteristic requires careful consideration regarding their definition and classifica-
tion as well as their interaction with other contextual elements and how they influence
health inequities. For example, there is no agreed-upon system for classifying race,
ethnicity, and culture, particularly across different countries (O’Neill et al. 2014).
PROGRESS-Plus is one acronym that can be used to describe disadvantage (O’Neill
et al. 2014; Evans and Brown 2003; Oliver et al. 2008). However, other frameworks for
describing disadvantage and inequity exist and may also be used to capture equity-
relevant data items. We support PROGRESS-Plus because it is easy to remember and is
inclusive of all factors that may indicate disadvantage. About 68 per cent of systematic
reviews describe the included population using one or more of the PROGRESS-Plus
criteria and 13 per cent assess the effects of interventions disaggregated across one or
more of these characteristics (Welch et al. 2012c).
Item 14: synthesis of results
Standard PRISMA item. Describe the methods of handling data and combining results of
studies, if done, including measures of consistency (e.g. I2) for each meta-analysis.
In addition, for equity-focused systematic reviews: Describe methods of synthesising
findings on health inequities (e.g. presenting both relative and absolute differences
between groups).
Example
● ‘Studies demonstrating an overall effect on anthropometric outcomes were initially
categorized according to whether they were effective or not effective among lower
SEP groups. Within these categories, we then analysed studies to identify common
characteristics between interventions, including the degree to which they addressed
structural barriers to behavioural change; as noted earlier, particular structural
barriers may be more or less prevalent among different SEP groups in a population.’
(Beauchamp et al. 2014)
Explanation – There is a need for a clear and explicit reporting of choices regarding analyses
about health inequity and their rationale a priori. This includes reporting what will be
compared and how these comparisons will be made. There are over 20 different approaches
available to measure health inequalities between two groups (e.g. rate ratio, rate difference,
low to high ratio) or between more than two groups (e.g. slope index of inequality, concen-
tration index, index of dissimilarity) (Harper et al. 2013). Despite vigorous debate about the
attributes, measurement properties, and implications of different measures and choice such as
the referent group, there is no single accepted measure of health inequalities, and all are
subject to limitations (Harper et al. 2010). Furthermore, the selection of how tomeasure health
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inequalities may bias the interpretation of results (Harper et al. 2013). For example, the
interpretation of any measure of changes in health inequalities over time depends on whether
the outcome is an adverse effect or beneficial outcome, and on the baseline prevalence
(Scanlan 2006). Authors should report the methods used to synthesise findings to ensure
sufficient information.
Figure 3 (Thomas et al. 2008)
Measures of health inequalities may be useful as an input for population or economic
models for projecting population impact on health inequalities. Considerations for choosing a
measure of health inequalities are: 1) interpretability; 2) ease of calculation; and 3) information
available from primary studies. While there is no agreement on the best approach, selection of
measures of health inequalities needs to consider the advantages, data requirements, and
limitations of these approaches. The choice of reference point (comparator), method of assessing
differences (relative or absolute), measurement of differences, or end of study outcomes affects
the difference observed between two or more groups (Keppel, Pamuk, and Lynch et al. 2005).
Some measures (e.g. Gini, concentration index) may be less well understood by the users.
The measurement of health inequity depends on characteristics of the outcome measure
and choices about comparisons, such as whether the outcome is desirable or undesirable,
baseline prevalence, and absolute or relative differences (Keppel, Pamuk, and Lynch et al.
2005; Scanlan 2014). This was demonstrated with a before–after study of a coronary artery
bypass graft (CABG) report card programme that compared the rates of CABG surgery
between white, black, and Hispanic patients. The relative difference decreased between white
and black patients for receipt of a CABG, but the absolute difference increased, therefore
increasing the disparities between ethnicities (Scanlan 2014;Werner, Asch, and Polsky 2005).
The absolute effect provides the difference in effectiveness between while the relative
effect describes the difference in effectiveness relative to a reference group, such as the
Figure 3. Harvest plot.
Source: The ‘harvest plot’ synthesises and displays the evidence to support possible social gradients
in the effects of the intervention (Thomas et al. 2008).
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whole population (Mackenbach and Kunst 1997). Absolute differences can describe the
proportion of the disadvantaged population affected, or not affected, by the intervention
since disadvantaged populations may have worse health status and a higher risk of adverse
outcomes (Scanlan 2014). Another example (Figure 4) demonstrates that while the rate of
stomach cancer mortality for men and women declined between the years 1930 and 2000,
the absolute difference between these rates decreased over that last 50 years while the
relative difference has increased steadily (Harper and Lynch 2005). This demonstrates that
although mortality rates have declined in both groups, the ratio of male-to-female stomach
cancer mortality has increased (more men than women are dying from stomach cancer). It
would be misleading to present one of these indicators without the others; therefore, we
suggest that systematic review authors present the absolute and relative differences.
If the aim of the intervention being studied in the systematic review is to reduce
inequities, authors should report how they plan to measure the effect on health inequities.
If the review will compare effects in two groups, how will the difference be measured,
synthesised, and interpreted at the systematic review level?
Figure 4 (Harper and Lynch 2005).
Item 16: additional analyses
Standard PRISMA item. Describe methods of additional analyses (e.g. sensitivity or
subgroup analyses, meta-regression), if done, indicating which were pre-specified.
In addition, for equity-focused systematic reviews: Describe methods of additional
synthesis approaches related to equity questions, if done, indicating which were pre-specified.
Examples
● ‘Effect modifiers, such as high/low energy, compliance, substitution, and duration of
the intervention were examined. In addition, study quality was considered since
Figure 4. Absolute and relative gender disparity in stomach cancer mortality, 1930–2000 (Harper
and Lynch 2005).
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studies of lower quality often show higher effect sizes than those of higher quality.
For example, biased outcome assessment is possible if the outcome assessors are
not blinded to study group. This review tabulated the effects for each study by
sorting them according to these effect modifiers (type of study, blinding versus
unclear blinding, date of study, and high versus low energy) (Kristjansson et al.
2007). The effect of school feeding on learning outcomes may also be affected by
contextual factors as teacher absenteeism and availability of learning materials,
both of which may be worse in more disadvantaged communities.’ (Kristjansson
et al. 2007)
● ‘This study examined the influence of program implementation, program activities,
program environment, and individual characteristics on welfare-to-work programs.
The authors also considered the unemployment rate for each to determine whether
the programs were affected by the availability of jobs in the area in which the
program was implemented.’ (Bloom 2005)
Explanation – Understanding how to reduce health inequities may require additional
quantitative or qualitative analyses, such as causal pathway analyses or process
evaluations and a greater use of subgroup analyses to explore the differential effects
of public health or population-level interventions. Implementation of an intervention
and its effectiveness may depend on participant characteristics such as age, education,
gender, social status, context including the presence of complementary services,
setting characteristics, and intervention characteristics (e.g. fidelity of intervention,
delivery). Differences in participant characteristics, context, and intervention design
or delivery may limit the ability to conduct a meta-analysis. These characteristics of
interventions, setting, and participants may not be well-reported in primary studies, or
have insufficient statistical power to find significant effects at the sub-group level
(Hoffmann et al. 2014; Burford et al. 2013a). Systematic review authors may need to
contact the primary study authors for information regarding subgroup analyses across
different characteristics such as ethnicity and socioeconomic status. This information
might have been analysed, but not reported in the published papers (Bhutta et al.
2011; Yousafzai et al. 2014) The move towards open access of trial data may make
this more feasible in the future (Godlee 2012).
Subgroup analyses need to be conducted with caution and follow guidelines for
reducing the likelihood of false results. Sun and colleagues have developed criteria for
judging the credibility of subgroup analyses such as pre-specifying the hypothesised
direction of effects, using a test for interaction, and keeping the number of subgroup
analyses few, and justified based on prior empiric evidence (Sun et al. 2010).
Systematic reviews with an equity focus should document and describe relevant and
important characteristics of the participants and settings, as well as implications for the
ability to conduct pre-planned analyses.
Numerous additional methods may be employed to assess the influence of contextual
factors, participant characteristics, and implementation such as qualitative review methods
to understand the process of implementation and its relationship to effectiveness (e.g.
using meta-ethnography, realist review, or thematic analysis) (Kastner et al. 2012). When
reporting the use of these methods, authors should use the relevant, method-specific
reporting guidance to transparently report their methods (e.g. RAMESES reporting guide-
lines for realist review or the Cochrane Handbook extension on qualitative reviews)
(Wong et al. 2013; Noyes et al. 2008).
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Results section
Item 18: study characteristics
Standard PRISMA item. For each study, present characteristics for which data were
extracted (e.g. study size, PICOS, follow-up period) and provide the citations.
In addition, for equity-focused systematic reviews: Present the population character-
istics that relate to the equity questions across the relevant PROGRESS-Plus or other
factors of interest.
Examples – Present the population characteristics that relate to the equity questions
across the relevant PROGRESS-Plus or other factors of interest.
● ‘Of the 82 studies included in this review, 55 studies (67%) were conducted in six
high income countries: Australia, Canada, Ireland, New Zealand, the UK, and the
USA. Forty-one of the 82 studies were conducted in the USA. Twelve studies
(14.6%) were conducted in eight middle income countries (Brazil, China, India,
Mexico, Philippines, Thailand, Turkey, and South Africa). Fifteen trials (18.3%)
were from 10 low income countries Bangladesh, Burkina Faso, Ethiopia, Ghana,
Iraq, Jamaica, Nepal, Pakistan, Tanzania, and Vietnam). In 59 studies the interven-
tion was delivered to patients based in their homes. Five interventions were based
solely in a primary care facility. . .A further eight studies involved a combination of
home, primary care, and community based interventions. Four studies delivered the
intervention mainly by telephone. . .while one implemented the intervention through
community meetings. For five studies, other sites were used such as the workplace,
churches, or homeless shelters.’ (Lewin et al. 2010)
● ‘Study participants had a mean age of 12.6 years and were described as of American
Indian descent and representing the Pueblo, Navajo, Hopi, and Jicarilla Apache
Indian Nations. The study setting was described as a boarding school exclusively for
American Indian youth and promoting academic excellence.’ (Jull et al. 2013)
Explanation – Approximately 50 per cent of systematic reviews report the effect of sex/
gender on outcomes, and less than 15 per cent report other PROGRESS-Plus character-
istics, which may be important (Tsikata et al. 2003; Welch et al. 2012c; Tugwell et al.
2008). PROGRESS-Plus information is reported in primary studies more often than in
systematic reviews (Tsikata et al. 2003; Tugwell et al. 2008). Reporting the characteristics
of populations associated with disadvantage, if relevant to the SR question, helps the user/
reader compare their own setting and population to those included in the studies and can
influence decision-making.
It may be useful to include criteria relating to judgements about which PROGRESS-
Plus factors are relevant for the review question. A number of frameworks are available to
help identify characteristics that are relevant in describing the socioeconomic and demo-
graphic characteristics of populations in addition to PROGRESS-Plus, such as SCRAP
(Sex, Comorbidities, Race, Age and Physiopathology) (Dans, Dans, and Guyatt 2008) and
SUPPORT Collaboration framework (Oxman et al. 2009). There is little empirical evi-
dence about the most efficient use of these frameworks. It is unlikely to be feasible to
report all characteristics of interest, and not all characteristics may be relevant for each
review. It is not necessary to report on all PROGRESS-Plus characteristics, as this might
encourage data dredging. However, authors should consider which factors are relevant to
their question a priori.
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Authors should report characteristics of the setting, and whether these characteristics are
entangled with the classification of disadvantage. For example, in the systematic review of
school feeding for disadvantaged children, disadvantage was identified by attributes of the
setting such as the location (poor, rural villages), the main occupation (e.g. ‘subsistence
farmers’), and the presence of school breakfast programmes, which were only funded and
provided in very poor areas with high malnutrition (Kristjansson et al. 2007).
Item 21: synthesis of results
Standard PRISMA item. Present results of each meta-analysis done, including confidence
intervals and measures of consistency.
In addition, for equity-focused systematic reviews: Present the results of synthesising
findings on inequities (see 14).
Example
● ‘This review sought to identify studies which had reported on sociodemographic
characteristics known to be important from an equity perspective. For this
process, the PROGRESS (Place, Race, Occupation, Gender, Religion,
Education, Socio-economic status (SES), Social status) framework was utilised.
All studies reported the gender of participants at baseline. Four studies reported
the race of participants and the level of education of parents. . .and two studies
included information about the employment status of parents at baseline. . .
included information on SES of participants at baseline based on parental
income. . . reported some indicators related to place (the proportion of participat-
ing schools in a rural or urban region) and SES (the proportion of participating
schools in an urban region which were also in an area considered to be under-
privileged). When analysing data on outcomes, only three studies analysed
results by any of the PROGRESS items. . . .analysed outcomes by gender. . .
analysed outcomes by the same indicators of place and SES that were collected
at baseline (these data are discussed above).’ (Waters et al. 2011)
Explanation – Authors should report the results of all analyses related to health
inequities and specify which analyses were determined a priori and which were con-
ducted post hoc. Raw values, as well as absolute and relative effects on health inequities
should be presented for the reasons discussed above. All analyses conducted at the
review level should be reported, even if they were lacking in data or were not statisti-
cally significant.
When examining the data across a population to identify population subgroups
experiencing disadvantage, interventions may have a greater absolute effect even if the
relative effect is the same. For example, a cohort of women smokers found that the
relative risk of coronary heart disease for cigarette smokers was slightly lower among
women with hypertension, hypercholesterolemia, or diabetes than among those without
them (Willett et al. 1987). However, the absolute (or attributable) risk was two or more
times higher for women with those conditions. Although the relative risk was lower, the
absolute risk was much higher because the baseline risk of coronary heart disease was so
much higher for non-smoking women with those conditions (Willett et al. 1987).
An SOF table is a recent requirement of Cochrane reviews, which presents the main
findings of the review and the quality of the evidence (Higgins and Green 2011) and are
intended for those using the review, such as decision-makers, and also facilitate the use of
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the review for developing guidelines and recommendations (Guyatt et al. 2011). The SOF
table is recommended to include seven patient-important outcomes. To appropriately
consider equity using SOF tables, the authors should consider three strategies: 1) include
an outcome related to health inequity to show whether the intervention enhanced health
equity (Table 4); (Lagarde and Palmer 2011)
2) consider whether disadvantaged populations have different baseline risk of the
important outcomes, and include a separate row in the summary of the finding table to
show the absolute events for disadvantaged groups (Table 5); (Imdad et al. 2010)
and 3) consider whether a separate SOF table is needed because of the expected
differences in relative effects (Table 6). (Brown, Platt, and Amos 2014b).
Item 23: additional analyses
Standard PRISMA item. Give results of additional analyses, if done (e.g. sensitivity or
subgroup analyses, meta-regression [see Item 16]).
In addition, for equity-focused systematic reviews: Give the results of additional
synthesis approaches related to equity objectives, if done (see 16).
Examples
● ‘Effect modifiers were age and socioeconomic status. Younger students had larger
effects than older students and students with lower socioeconomic status (SES) had
larger effects than those with higher SES.’ (Wilson and Lipsey 2007)
Table 4. Example of a summary of findings table that includes an outcome related to health
inequity.
The impact of user fees on access to health services in low- and middle-income countries
Population: Anyone using any type of health service in low- and middle-income countries.
Settings: Burkina Faso, Kenya, Lesotho, Papua New Guinea.
Intervention: Introducing or increasing user fees
Comparison: No fees
Outcomes Relative change
in utilisation
(Rio Political
Declaration
on Social
Determinants
of Health 2011)
Number of
studies
Quality of the
evidence
(GRADE)
Comments
Equity outcome –
health
utilisation by
quartile
N/A 1 ⊕⊖⊖⊖
Very low
This study where quality
improvements were
introduced at the same
time as user fees found
an increase in utilisation
for poor groups. The
authors did not report
the results in a way that
the relative change in
utilisation could be
calculated.
Note: CI, Confidence Interval; RR, Relative Risk (Lagarde and Palmer 2011).
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● ‘This review used weighted regression analyses to investigate which elements of the
programs were independently related to bullying and victimization effect sizes. These
analyses showed that the most important elements of the program that were related to a
Table 6. Example of a separate summary of findings table because of the expected differences for
the disadvantaged population.
Summary equity impact of included studies and policies
Positive Neutral Negative Mixed Unclear Total
Increases in price/tax of tobacco products 14 6 4 1 2 27
Smoke free – voluntary, regional, partial 1 1 19 0 4 25
Smoke free – compulsory, national,
comprehensive
2 9 6 1 4 19
Mass media campaigns 3 2 5 2 6 18
Mass media campaigns – quitlines and
nicotine replacement therapy
5 3 3 0 1 12
Controls on advertising, promotion, and
marketing of tobacco
2 7 0 0 9
Population-level cessation support
interventions
4 2 0 1 2 9
Settings-based interventions (community,
workplace, hospital)
2 4 1 0 0 7
Multiple policies 0 2 0 1 1 4
Total policies 33 36 38 6 17 130
Total studies 31 30 37 6 14 117
Table 5. Example of a summary of findings table that includes a separate row to show the absolute
events for disadvantaged groups.
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Patient or population: Children aged between 6 months and five years
Intervention: Vitamin A supplementation
Comparison: Placebo or usual care
Outcomes Illustrative comparative
risks (95% CI)
Relative effect
(95% CI)
No. of
Participants
(studies)
Quality of the
evidence
(GRADE)
Comments
Diarrhoea-related
mortality
Follow-up:
48–104 weeks
Low-risk population RR 0.72; 95%
CI 0.57 to 0.91
90,951
(7 studies)
+++O
moderate
Total number of
participants
reflects number
randomised to
studies. The
analysis
combined
cumulative risk
and risk per/
1000 years
follow-up.
3 per 1000 2 per 1000
(2 to 3)
Medium-risk population
4 per 1000 3 per 1000
(2 to 4)
High-risk population
9 per 1000 6 per 1000
(5 to 8)
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decrease in bullying were parent training/meetings and disciplinary methods. Of all the
intensity and duration factors, the most important program elements were intensity for
children and parent training/meetings.’ (Farrington and Ttofi 2009)
Explanation – The results of any additional syntheses related to the equity objectives
should be reported as well as whether they were planned a priori and specified in the
review protocol. This is consistent with published best practice in subgroup analysis (Sun
et al. 2010). Subgroup analyses can be inappropriate, poorly specified, and prone to Type
I and Type II error; therefore, all subgroup analyses need to be interpreted cautiously.
Subgroup analyses in systematic reviews are generally reported with insufficient detail to
judge their credibility (Sun et al. 2012).
Subgroups that were not identified at the protocol stage may be identified post hoc;
however, the rationale for these analyses should be reported. Authors should report all subgroup
analyses and any analyses to assess effect modifiers such as meta-regression – both statistically
significant and non-significant to avoid outcome reporting bias of reporting only statistically
significant results (Boutron et al. 2010). This may be difficult, as effect modifiers may not be
clearly reported in the primary studies. In some cases, there may be too few studies in particular
settings of interest to draw conclusions. Intervention effects can be influenced by their design
and implementation as well as the context within which it was implemented. For example, in
the school feeding review, learning outcomes such as mathematics achievement were found to
be higher with school meals programmes, but context was important for this outcome; if there
were no teachers then there was no change in educational achievement with feeding.
Analyses related to contextual factors should be fully reported including a description
of whether data was lacking from primary studies.
Discussion section
Item 26: conclusions
Standard PRISMA item. Provide a general interpretation of the results in the context of
other evidence, and implications for future research.
In addition, for equity-focused systematic reviews: Present extent and limits of applic-
ability to disadvantaged populations of interest and describe the evidence and logic
underlying those judgements.
Example
● ‘This review included studies from high income countries as well as lower-middle-
and upper-middle-income countries, with five studies conducted in countries within
the latter two groupings (Thailand, Brazil, Chile and Mexico). This means that,
while predominantly conducted within high-income settings, the findings from this
review may be generalisable to a number of settings. A total of nineteen studies
specifically reported incorporating strategies to target socio-economic and/or cul-
tural diversity or disadvantage. One such study was conducted outside of the high-
income country setting, in Chile, an upper-middle-income country. Of the remaining
eighteen studies, seven studies conducted in the USAwere of interventions targeting
African American children and their communities and another two studies targeted
Native American communities. Other studies targeted participants of low socio-
economic status, or were implemented in areas of social disadvantage. By far the
most common setting for interventions included in this review were schools (43
studies). Other interventions were (or included) home-based (14 studies),
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community based (six studies), or were set in a health service (two studies) or care
setting (two studies). Eleven studies incorporated interventions across multiple
settings.’ (Waters et al. 2011)
Explanation – The conclusion should provide a transparent assessment of the applic-
ability, the transferability, and the generalisability of the findings to the specific disad-
vantaged populations of interest (recognising it is impossible to make these judgments for
all possible populations). Authors should clearly report any disadvantaged population that
was specified in the protocol and the reasons that consideration was given to the applic-
ability of the results to the specified population. The applicability of the findings of a
review to disadvantaged populations should be addressed similarly to considerations of
applicability to any other population (Lavis 2009; Guyatt et al. 2011; Dans, Dans, and
Guyatt 2008; Dans et al. 2007; Schünemann et al. 2011).
Authors should specify disadvantaged populations or settings for which the interven-
tion is likely to be relevant. In the discussion review authors should consider the potential
impact of: economic status, employment or occupation, education, place of residence,
gender, and ethnicity as potential influences on the applicability of the results to dis-
advantaged populations, as well as resource or capacity constraints, health system arrange-
ments or baseline conditions as potential reasons for there being a difference in the
potential applicability of the results to low-income countries or disadvantaged popula-
tions. Authors should justify any judgments about applicability using transparent methods.
There is no agreed-upon checklist for judging applicability, although many are available
(Burford et al. 2013a; Welch et al. 2012a). However, authors should provide rationale, and
any data used to make judgements about applicability.
Applicability of results is often overlooked in systematic reviews. For example, an
assessment of systematic reviews related to public health found that only 13 per cent
discussed applicability (Ahmad et al. 2010). The panel felt that the conclusion of an
equity-focused systematic review should provide a transparent assessment of the applic-
ability, the transferability, and the generalisability of the findings to at least one specific
disadvantaged population of interest. This population should be pre-specified in the
protocol with rationale. Authors should also specify additional disadvantaged populations
or settings for which the intervention is likely to be relevant.
The applicability of the findings of a review to disadvantaged populations should be
addressed similarly to considerations of applicability to any other population, using
explicit methods (Lavis 2009; Guyatt et al. 2011; Dans, Dans, and Guyatt 2008; Dans
et al. 2007; Schünemann et al. 2011). There is no agreed-upon checklist for judging
applicability, although many checklists are available (Burford et al. 2013a). Authors
should provide a rationale for the method they choose, and any data used to make
judgements about applicability, such as other evidence about the possible impact of
economic status, employment or occupation, education, place of residence, gender, and
ethnicity, as well as resource or capacity constraints, health system arrangements or
baseline conditions.
Item 26A: in addition, for equity-focused systematic reviews: Provide implications for
research, practice, or policy related to equity where relevant (e.g. types of research
needed to address unanswered questions).
Examples
● ‘The body of evidence in this review provides some support for the hypothesis that
obesity prevention interventions in children can be effective, and where examined,
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have not caused adverse outcomes or increased health inequalities. To this end, the
direction of research and evaluation must move into how to implement effectively to
scale, sustain the impacts over time and ensure equitable outcomes. In addition,
interventions need to be developed that can be embedded into ongoing practice and
operating systems, rather than implementing interventions that are resource intensive
and cannot be maintained long-term.’ (Waters et al. 2011)
● ‘Future research should promote the development of effective interventions to
enhance the online health literacy of consumers. Thus there is a need for well-
designed and rigorously conducted randomised controlled trials (RCTs). These
RCTs should involve diverse participants (regarding disease status, age, socio-
economic group and gender) to analyse to what extent online health literacy reduces
a barrier to using the internet for health information, or if socio-economic group,
gender and age are more important in influencing internet use. Trials should be
conducted in different settings (including low, middle and high income countries)
and should examine interventions to enhance consumers online health literacy
(search, appraisal and use of online health information) like internet training
courses.’ (Car et al. 2011)
Explanation – Implications for research, practice, and policy should highlight the effects
on equity. This section of the review should state the research that needs to be done to
address existing knowledge gaps and should also suggest what the unanswered research
questions are – that is, by specifying the questions that still need answering instead of
stating that we ‘need more research’.
Discussion
We developed the PRISMA-E 2012 checklist following guidance suggested by Moher and
colleagues (Moher et al. 2010). This reporting guideline is intended to improve transpar-
ency and completeness of reporting of equity-focused systematic reviews. Improved
reporting can lead to better judgement of applicability by policymakers, which may result
in more appropriate policies and programmes and may lead to reductions in health
inequities.
This explanation and elaboration document is intended to accompany the PRISMA-E
2012 Statement to improve understanding of the reporting guideline for users (Welch et al.
2012b). The original PRISMA Statement has been endorsed by almost 200 journals;
therefore, we recommend that authors of equity-focused systematic reviews use both the
PRISMA checklist and the PRISMA-E 2012 checklist.
Potential limitations of the PRISMA-E 2012 checklist are that certain terminologies
used in the reporting guideline may not be well defined or widely used and may be
defined differently by different users. To mitigate these concerns, we pilot tested the
checklist with different groups of systematic reviews authors including those in high-
income as well as low- and middle-income countries. The results of these pilot tests have
been reported elsewhere (Burford et al. 2013b). While some of the PRISMA-E 2012
extension items may apply to non-equity-focused reviews, we felt that their importance
for equity-focused reviews was great enough to warrant development of a specific
reporting guideline for these reviews. In addition, there is no planned update of the
PRISMA Statement so we have included them in this reporting guideline.
We are committed to a broad-based dissemination strategy of PRISMA-E 2012 and
hope to have endorsement by all journals endorsing the PRISMA Statement. Our
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dissemination strategy includes contact with journal editors, systematic review authors
and trainers, and dissemination at meetings and conferences. We will continue to monitor
endorsement of the checklist by journal editors. We plan to evaluate this reporting
guideline at a future date to determine its impact on the reporting of equity-focused
systematic reviews. We will measure the ‘footprint’ of PRISMA-E 2012 by tracking the
number of requests for support (e.g. emails, phone calls), and indicators of sharing of
PRISMA-E 2012 through various networks, such as LinkedIn, Twitter, and Facebook. We
will also measure web metrics, such as downloads of the Word file of the reporting
guideline checklist from our website.
We hope that journal endorsement and implementation, and use by systematic
reviewers will improve the reporting of equity-focused systematic reviews. Widespread
use of the PRISMA-E 2012 checklist may increase the requests for more data from
primary researchers, which may in turn improve the reporting of equity considerations
in primary research.
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